People

Julie Gilmore
Eli Lilly vice president and global head of Lilly Gateway Labs, and TRexBio director. Has held scientific and leadership roles in research and drug development; trained in membrane biophysics and drug transport. Julie Gilmore leads Lilly Gateway Labs and Catalyze360 portfolio management as vice president and global head. Her Lilly career spans research, scientific communications, European clinical operations and neurodegeneration/pain portfolio management. She trained in membrane biophysics at Purdue and drug transport at Indiana University.
Roles
TRexBio
CurrentBoard Member
Eli Lilly and Company
CurrentVice President and Global Head, Lilly Gateway Labs and Catalyze360 Portfolio Management